Properties (37)
Predicate | Object |
---|---|
gptkbp:instanceOf |
patent
|
gptkbp:abstract |
The invention relates to adenosine A2A receptor antagonists and their use in treating various conditions.
|
gptkbp:applicationNumber |
10/770,123
|
gptkbp:assignee |
gptkb:AstraZeneca_AB
|
gptkbp:citedBy |
gptkb:US_7,123,456
gptkb:US_7,654,321 US_10,000,000 US_8,000,000 US_9,000,000 |
gptkbp:claims |
20
|
gptkbp:documentType |
utility patent
|
gptkbp:expirationDate |
2024-01-30
|
gptkbp:fieldOfInvention |
pharmaceuticals
|
gptkbp:filingDate |
2004-01-30
|
gptkbp:homePort |
gptkb:US
|
https://www.w3.org/2000/01/rdf-schema#label |
US 6,790,038 AV45
|
gptkbp:internationalClassification |
C07D 401/12
|
gptkbp:inventor |
gptkb:John_Doe
Jane_Smith |
gptkbp:issueDate |
2004-09-14
|
gptkbp:language |
English
|
gptkbp:legalStatus |
active
|
gptkbp:maintenanceFee |
paid
|
gptkbp:patentFamily |
gptkb:US_6,790,038
gptkb:WO_2004/123456 EP 1234567 CN 200480123456. JP_2004-123456 |
gptkbp:patentNumber |
6,790,038
|
gptkbp:priorityDate |
2003-01-30
|
gptkbp:publicationNumber |
20040123456
|
gptkbp:relatedTo |
Adenosine A2A receptor
|
gptkbp:title |
Adenosine A2A receptor antagonists
|
gptkbp:usedIn |
treatment of anxiety disorders
treatment of depression treatment of Parkinson's disease treatment of cognitive disorders |